North Miami Beach, FL – According to filings with the U.S. Securities and Exchange Commission, Vector Vitale is raising $30,000,000.00 in new funding. Sources indicate as part of senior management President, Max Temnik played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vector Vitale

Vector Vitale was founded in 2015, following more than 20 years of extensive research in mathematical models of hierarchical stable systems, physics of the atom, and nature of changes in biomolecules structure. Our interdisciplinary studies resulted in a new model of pathogenesis and novel methods for prevention and treatment of degenerative diseases. Our vision is to change the paradigm of treatment for patients with degenerative diseases by addressing the fundamental factors which define the onset and progress of pathologies. We aim to change how the degenerative diseases are defined.

To learn more about Vector Vitale, visit http://vectorvitale.com/

Contact:
Max Temnik, President
786-777-8835
https://www.linkedin.com/in/max-temnik-b71b2182/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved